UBE2E1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.836200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.946080E-02
Normal-vs-Stage2
8.636300E-02
Normal-vs-Stage3
4.255800E-02
Normal-vs-Stage4
4.279800E-01
Stage1-vs-Stage2
2.559000E-01
Stage1-vs-Stage3
7.970200E-01
Stage1-vs-Stage4
3.272100E-02
Stage2-vs-Stage3
2.256800E-01
Stage2-vs-Stage4
1.817230E-01
Stage3-vs-Stage4
5.469700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.334300E-02
Normal-vs-AfricanAmerican
1.726470E-02
Normal-vs-Asian
1.361840E-01
Caucasian-vs-AfricanAmerican
3.316400E-01
Caucasian-vs-Asian
8.783400E-01
AfricanAmerican-vs-Asian
5.037800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.483800E-02
Normal-vs-Female
8.394500E-02
Male-vs-Female
4.540400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.418200E-01
Normal-vs-Age(41-60Yrs)
1.447800E-01
Normal-vs-Age(61-80Yrs)
4.704100E-02
Normal-vs-Age(81-100Yrs)
4.489600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.043600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.151600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.923600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.391800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.549800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.095800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.084180E-01
Normal-vs-Daily Drinker
2.588500E-02
Normal-vs-Weekly Drinker
1.076600E-01
Normal-vs-Occasional Drinker
1.983200E-01
Normal-vs-Social Drinker
1.495580E-01
Non Drinker-vs-Daily Drinker
3.331600E-01
Non Drinker-vs-Weekly Drinker
7.449000E-01
Non Drinker-vs-Occasional Drinker
2.830400E-01
Non Drinker-vs-Social Drinker
8.587200E-01
Daily Drinker-vs-Weekly Drinker
2.267800E-01
Daily Drinker-vs-Occasional Drinker
4.374400E-02
Daily Drinker-vs-Social Drinker
5.466200E-01
Weekly Drinker-vs-Occasional Drinker
4.989800E-01
Weekly Drinker-vs-Social Drinker
6.712000E-01
Occasional Drinker-vs-Social Drinker
2.966600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.653400E-01
Normal-vs-Grade 2
9.084600E-01
Normal-vs-Grade 3
8.745000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.745900E-02
Grade 1-vs-Grade 3
2.052400E-02
Grade 1-vs-Grade 4
9.653400E-01
Grade 2-vs-Grade 3
4.550200E-01
Grade 2-vs-Grade 4
9.084600E-01
Grade 3-vs-Grade 4
8.745000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.070400E-02
Normal-vs-NonDiabetic
6.170500E-02
Diabetic-vs-NonDiabetic
7.260400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.028100E-02
Normal-vs-NoPancreatitis
6.892100E-02
Pancreatitis-vs-NoPancreatitis
8.150400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.639600E-02
Normal-vs-N1
8.266300E-02
N0-vs-N1
6.354200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.161800E-01
Normal-vs-TP53-NonMutant
1.515960E-02
TP53-Mutant-vs-TP53-NonMutant
5.72810000000201E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
